0001893917-21-000001.txt : 20211115 0001893917-21-000001.hdr.sgml : 20211115 20211115155649 ACCESSION NUMBER: 0001893917-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 EFFECTIVENESS DATE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Imel Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001893917 IRS NUMBER: 364930894 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-421205 FILM NUMBER: 211409968 BUSINESS ADDRESS: STREET 1: 303 WYMAN STREET, SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 972-544506092 MAIL ADDRESS: STREET 1: 303 WYMAN STREET, SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001893917 Imel Biotherapeutics, Inc. 303 WYMAN STREET, SUITE 300 WALTHAM MA MASSACHUSETTS 02451 972-544506092 DELAWARE None None Corporation true 2019 Silvia Noiman, Ph.D. c/o Imel Biotherapeutics, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Tomer Kariv c/o Imel Biotherapeutics, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director Taro Inaba c/o Imel Biotherapeutics, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director Dori Pelled c/o Imel Biotherapeutics, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Executive Officer Other Health Care Decline to Disclose 06b false 2021-10-29 false true false 0 20049713 15049713 5000000 false 5 0 0 0 false Imel Biotherapeutics, Inc. /s/ Silvia Noiman, Ph.D. Silvia Noiman, Ph.D. Chief Executive Officer 2021-11-15